Article
De novo triplication at 1p36.23p36.22 further refines the dosage sensitive region of overlap in Setleis syndrome (focal facial dermal dysplasia type III).
American journal of medical genetics. Part A - 1 Jun 2023
Oh Rachel Youjin, Chun Kathy, Kowalski Paul E, Chitayat David
Abstract excerpt
Setleis syndrome (SS), or focal facial dermal dysplasia type III (FFDD3, MIM #227260), is an autosomal recessive condition caused by biallelic loss-of-function variants in TWIST2. It is characterized by bitemporal atrophic skin lesions and distinctive facial features. Individuals with de novo or inherited duplication or triplication of the chromosomal region 1p36.22p36.21 have also been reported to have the SS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
